Association of P2Y12 gene promoter DNA methylation with the risk of clopidogrel resistance in coronary artery disease patients

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Su, Jia ^a   Li, Xiaojing ^a   Yu, Qinglin ^a   Liu, Yahui ^a   Wang, Yaqing ^a   Song, Haojun ^a   Cui, Hanbin ^a   Du, Weiping ^a   Fei, Xiaohong ^a   Liu, Junsong ^a   Lin, Shaoyi ^a   Wang, Jian ^a   Zheng, Wenyuan ^a   Zhong, Jinyan ^a   Zhang, Lulu ^a   Tong, Maoqing ^a   Xu, Jin ^b   Chen, Xiaomin ^a  

^a NINGBO FIRST HOSPITAL   (China)

^b NINGBO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALCOHOL; BISULFITE; C REACTIVE PROTEIN; CLOPIDOGREL; DINUCLEOTIDE; DNA; NITROGEN; PURINERGIC P2Y12 RECEPTOR; TRIACYLGLYCEROL; UREA; P2RY12 PROTEIN, HUMAN; PURINERGIC P2Y RECEPTOR ANTAGONIST; TICLOPIDINE;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CPG ISLAND; DNA METHYLATION; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MALE; PLATELET REACTIVITY; POLYMERASE CHAIN REACTION; PROMOTER REGION; PYROSEQUENCING; SMOKING; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION ANALYZER; UREA NITROGEN BLOOD LEVEL; ANALOGS AND DERIVATIVES; DRUG EFFECTS; DRUG RESISTANCE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR; TREATMENT FAILURE;

AGED; CORONARY ARTERY DISEASE; DNA METHYLATION; DRUG RESISTANCE; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; RISK FACTORS; TICLOPIDINE; TREATMENT FAILURE;

EID: 84897569158     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/450814     Document Type: Article

References (35)

1. Kunapuli S. P., Dorsam R. T., Kim S., Quinton T. M., Platelet purinergic receptors. Current Opinion in Pharmacology 2003 3 2 175 180 2-s2.0-0037386253 10.1016/S1471-4892(03)00007-9 (Pubitemid 36411242)
2. Wright R. S., Anderson J. L., Adams C. D., Bridges C. R., Casey D. E. Jr., Ettinger S. M., Fesmire F. M., Ganiats T. G., Jneid H., Lincoff A. M., Peterson E. D., Philippides G. J., Theroux P., Wenger N. K., Zidar J. P., Anderson J. L., Adams C. D., Antman E. M., Bridges C. R., Califf R. M., Casey D. E. Jr., Chavey W. E., Fesmire F. M., Hochman J. S., Levin T. N., Lincoff A. M., Peterson E. D., Theroux P., Wenger N. K., Wright R. S., 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular. Journal of the American College of Cardiology 2011 57 19 1920 1959 2-s2.0-79960065486
3. Gurbel P. A., Bliden K. P., Hiatt B. L., O'Connor C. M., Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003 107 23 2908 2913 2-s2.0-0038649988 10.1161/01.CIR.0000072771.11429.83 (Pubitemid 36736631)
4. Matetzky S., Shenkman B., Guetta V., Shechter M., Bienart R., Goldenberg I., Novikov I., Pres H., Savion N., Varon D., Hod H., Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004 109 25 3171 3175 2-s2.0-8344221349
5. Hochholzer W., Trenk D., Bestehorn H.-P., Fischer B., Valina C. M., Ferenc M., Gick M., Caputo A., Büttner H. J., Neumann F.-J., Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. Journal of the American College of Cardiology 2006 48 9 1742 1750 2-s2.0-33750479499 10.1016/j.jacc.2006.06.065 (Pubitemid 44648629)
6. Karaźniewicz-Łada M., Danielak D., Główka F., Genetic and non-genetic factors affecting the response to clopidogrel therapy. Expert Opinion on Pharmacotherapy 2012 13 5 663 683 2-s2.0-84858637979 10.1517/14656566.2012.666524
7. Campo G., Fileti L., Valgimigli M., Tebaldi M., Cangiano E., Cavazza C., Marchesini J., Ferrari R., Poor response to clopidogrel: current and future options for its management. Journal of Thrombosis and Thrombolysis 2010 30 3 319 331 2-s2.0-77957954848 10.1007/s11239-010-0457-5
8. Razin A., Webb C., Szyf M., Variations in DNA methylation during mouse cell differentiation in vivo and in vitro. Proceedings of the National Academy of Sciences of the United States of America 1984 81 8 2275 2279 2-s2.0-0021366951 (Pubitemid 14148245)
9. Fatemi M., Pao M. M., Jeong S., Gal-Yam E. N., Egger G., Weisenberger D. J., Jones P. A., Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level. Nucleic Acids Research 2005 33 20 e176.1 e176.9 2-s2.0-29144435153 10.1093/nar/gni180 (Pubitemid 41806404)
10. Morita S., Takahashi R. U., Yamashita R., Toyoda A., Horii T., Kimura M., Fujiyama A., Nakai K., Tajima S., Matoba R., Genome-wide analysis of DNA methylation and expression of microRNAs in breast cancer cells. International Journal of Molecular Sciences 2012 13 7 8259 8272 10.3390/ijms13078259
11. Cuisset T., Frere C., Quilici J., Morange P.-E., Saut N., Lambert M., Camoin L., Vague I. J., Bonnet J.-L., Alessi M.-C., Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome. Thrombosis Research 2007 120 6 893 899 2-s2.0-34548722718 10.1016/j.thromres.2007.01.012 (Pubitemid 47432706)
12. Kim I.-S., Jeong Y.-H., Kang M.-K., Koh J.-S., Park Y., Hwang S.-J., Kwak C. H., Hwang J.-Y., Kim S., Correlation of high post-treatment platelet reactivity assessed by light transmittance aggregometry and the VerifyNow P2Y12 assay. Journal of Thrombosis and Thrombolysis 2010 30 4 486 495 2-s2.0-80053369628
13. Marcucci R., Gori A. M., Paniccia R., Giusti B., Valente S., Giglioli C., Buonamici P., Antoniucci D., Abbate R., Gensini G. F., Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay a 12-month follow-up. Circulation 2009 119 2 237 242 2-s2.0-59849120163 10.1161/CIRCULATIONAHA.108.812636
14. Grützmann R., Molnar B., Pilarsky C., Habermann J. K., Schlag P. M., Saeger H. D., Miehlke S., Stolz T., Model F., Roblick U. J., Bruch H.-P., Koch R., Liebenberg V., deVos T., Song X., Day R. H., Sledziewski A. Z., Lofton-Day C., Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS ONE 2008 3 11 2-s2.0-56649094216 10.1371/journal.pone. 0003759 e3759
15. DeVos T., Tetzner R., Model F., Weiss G., Schuster M., Distler J., Steiger K. V., Grützmann R., Pilarsky C., Habermann J. K., Fleshner P. R., Oubre B. M., Day R., Sledziewski A. Z., Lofton-Day C., Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clinical Chemistry 2009 55 7 1337 1346 2-s2.0-67650077151 10.1373/clinchem.2008.115808
16. Müller H. M., Fiegl H., Widschwendter A., Widschwendter M., Prognostic DNA methylation marker in serum of cancer patients. Annals of the New York Academy of Sciences 2004 1022 44 49 2-s2.0-3242722057 10.1196/annals.1318. 008 (Pubitemid 38951580)
17. Müller H. M., Widschwendter A., Fiegl H., Ivarsson L., Goebel G., Perkmann E., Marth C., Widschwendter M., DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Research 2003 63 22 7641 7645 2-s2.0-18544406053 (Pubitemid 37466689)
18. Guay S.-P., Brisson D., Munger J., Lamarche B., Gaudet D., Bouchard L., ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia. Epigenetics 2012 7 5 464 472 2-s2.0-84860596947
19. Xu H., Wang B., Su D., Yu Q., Li Q., Kou C., Shi J., Yu Y., Ma X., The DNA methylation profile of PLA2G4C gene promoter in schizophrenia. Psychiatry Research 2012 200 2-3 1079 1081 10.1016/j.psychres.2012.07.003
20. Shi R., Ge L., Zhou X., Ji W. J., Lu R. Y., Zhang Y. Y., Zeng S., Liu X., Zhao J. H., Zhang W. C., Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity. Thrombosis Research 2013 131 6 508 513 10.1016/j.thromres.2013.02.015
21. Gagne J. J., Bykov K., Choudhry N. K., Toomey T. J., Connolly J. G., Avorn J., Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison. British Medical Journal 2013 347 f5307
22. Zhang L. N., Liu P. P., Wang L., Yuan F., Xu L., Xin Y., Fei L. J., Zhong Q. L., Huang Y., Hao L. M., Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension. PloS ONE 2013 8 5 e63455
23. Sun Y. V., Lazarus A., Smith J. A., Chuang Y. H., Zhao W., Turner S. T., Kardia S. L., Gene-specific DNA methylation association with serum levels of C-reactive protein in African Americans. PloS ONE 2013 8 8 e73480
24. Gehrke S., Brueckner B., Schepky A., Klein J., Iwen A., Bosch T. C., Wenck H., Winnefeld M., Hagemann S., Epigenetic regulation of depot-specific gene expression in adipose tissue. PloS ONE 2013 8 12 e82516
25. Breton C. V., Byun H.-M., Wenten M., Pan F., Yang A., Gilliland F. D., Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. American Journal of Respiratory and Critical Care Medicine 2009 180 5 462 467 2-s2.0-69249132169 10.1164/rccm.200901-0135OC
26. Hicks S. D., Middleton F. A., Miller M. W., Ethanol-induced methylation of cell cycle genes in neural stem cells. Journal of Neurochemistry 2010 114 6 1767 1780 2-s2.0-77956306367 10.1111/j.1471-4159.2010.06886.x
27. Motsinger A. A., Ritchie M. D., The effect of reduction in cross-validation intervals on the performance of multifactor dimensionality reduction. Genetic Epidemiology 2006 30 6 546 555 2-s2.0-33747613579 10.1002/gepi.20166 (Pubitemid 44267170)
28. Gaborit B., FrèRe C., Cuisset T., Alessi M.-C., Dutour A., Enhanced post-clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic control. Journal of Thrombosis and Haemostasis 2009 7 11 1939 1941 2-s2.0-70449442585 10.1111/j.1538-7836.2009.03599.x
29. Kuliczkowski W., Gasior M., Pres D., Kaczmarski J., Greif M., Łaszewska A., Szewczyk M., Hawranek M., Tajstra M., Zegleń S., Poloński L., Serebruany V., Effect of glycemic control on response to antiplatelet therapy in patients with diabetes mellitus and ST-segment elevation myocardial infarction. American Journal of Cardiology 2012 110 3 331 336 2-s2.0-84860559823 10.1016/j.amjcard.2012.03.027
30. Park S. H., Kim W., Park C. S., Kang W. Y., Hwang S. H., Kim W., A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure. American Journal of Cardiology 2009 104 9 1292 1295 2-s2.0-71749116951 10.1016/j.amjcard.2009.06.049
31. Muller C., Caillard S., Jesel L., El Ghannudi S., Ohlmann P., Sauleau E., Hannedouche T., Gachet C., Moulin B., Morel O., Association of estimated GFR with platelet inhibition in patients treated with clopidogrel. American Journal of Kidney Diseases 2012 59 6 777 785 2-s2.0-84858057557 10.1053/j.ajkd.2011.12. 027
32. Park D.-W., Lee S.-W., Yun S.-C., Song H.-G., Ahn J.-M., Lee J.-Y., Kim W.-J., Kang S.-J., Kim Y.-H., Lee C. W., Park S.-W., Park S.-J., A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation. Journal of the American College of Cardiology 2011 58 25 2630 2639 2-s2.0-82955189275 10.1016/j.jacc.2011.08.057
33. Geisler T., Mueller K., Aichele S., Bigalke B., Stellos K., Htun P., Ninci E., Fateh-Moghadam S., May A. E., Gawaz M., Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions. Clinical Research in Cardiology 2010 99 11 743 752 2-s2.0-78649649127 10.1007/s00392-010-0179-x
34. Morel O., El Ghannudi S., Hess S., Reydel A., Crimizade U., Jesel L., Radulescu B., Wiesel M. L., Gachet C., Ohlmann P., The extent of P2Y12 inhibition by clopidogrel in diabetes mellitus patients with acute coronary syndrome is not related to glycaemic control: roles of white blood cell count and body weight. Thrombosis and Haemostasis 2012 108 2 338 348 10.1160/TH11-12-0876
35. Malek L. A., Kisiel B., Spiewak M., Grabowski M., Filipiak K. J., Kostrzewa G., Huczek Z., Ploski R., Opolski G., Coexisting polymorphisms of P2Y12 and CYP2C19 genes as a risk factor for persistent platelet activation with clopidogrel. Circulation Journal 2008 72 7 1165 1169 2-s2.0-46849109542 10.1253/circj.72.1165 (Pubitemid 351957086)